Severe Pulmonary Arteriopathy in a Neonate with Congenital Rubella Syndrome and Patent Ductus Arteriosus
- 7 Downloads
Neonates with congenital rubella syndrome (CRS) are known to have associated congenital cardiac malformations. Patent ductus arteriosus (PDA) is one the most common cardiac anomalies associated with CRS. PDA refractory to medical management and associated with ventilatory dependence is considered for surgical ligation. However, the management of PDA can be challenging in the presence of underlying lung disease or pulmonary vascular disease. Outcomes after closure in neonates are dependent upon age, weight, nutritional status, pre-operative pulmonary arterial hypertension and presence of chronic lung disease. We present a neonate with CRS who required surgical PDA closure. The neonate developed severe pulmonary arterial hypertension which led to fatal outcome. The clinical course is corroborated with histo-pathological changes observed on the autopsy of this neonate.
KeywordsComplications Epidemiology German measles Pregnancy
Unable to display preview. Download preview PDF.
Prof Ashim Das for conducting autopsy, providing us with essential information regarding histopathological findings and modification and approval of pathology protocol.
Funding: None; Competing interest: None stated.
- 1.World Health Organization; WHO 2014. WHO-recommended Surveillance Standard of Rubella and Congenital Rubella Syndrome: Available from http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/rubella_standards/en. Accessed December 11, 2017.
- 2.Mace M, Cointe D, Six Caroline, Levy-Bruhl D, Chatelet IP, Ingrand D, et al. Diagnostic value of Reverse Transcription- PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection. J Clin Microbiol. 2004;42:4818–20.CrossRefGoogle Scholar
- 8.World Health Organization. WHO 2018. Global and Regional Immunization Profile South-East Asia Region. Available from: http://www.who.int/immunization/monitoring_surveillance/data/gs_searprofile.pdf. Accessed November 3, 2018.
- 9.Lanzieri T, Redd S, Abernathy E, Icenogle J. Congenital Rubella Syndrome. Centers for Disease Control and Prevention 2018. Available from: https://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html. Accessed December 12, 2018
- 10.Dobson RS, Edwards SM, Weisman LE, Armsby C. Uptodate 2018. Congenital Rubella Syndrome: Clinical Features and Diagnosis. Available from: https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis. Accessed December 12, 2018.
- 11.Rao JN, Chancham S, Reddy UN, Nagasravani J, Mazher N, Mustafa ST. Congenital rubella syndrome with basal ganglia calcification and bilateral nuclear cataracts in a neonate: A rare entity. Sch J Med Case Rep. 2014;2:470–2.Google Scholar
- 14.Cherry JD, Adachi K. Rubella virus. In: Cherry JD, Harrison GJ, Kaplan SL, editors. Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th ed, Philadelphia: Elsevier Saunders, 2014. P. 2195.Google Scholar
- 18.Zhang DZ, Zhu XY, Lv B, Cui CS, Han XM, Sheng XT, et al. Trial occlusion to assess the risk of persistent pulmonary arterial hypertension after closure of a large patent ductus arteriosus in adolescents and adults with elevated pulmonary artery pressure. Circ Cardiovasc Interv. 2014;7:473–81.CrossRefGoogle Scholar